This study aimed to identify time parameters predicting favourable CRT response. A total of 38 patients with ischemic cardiomyopathy, qualified for CRT implantation, were enrolled in the study. A 15% reduction in indexed end-systolic volume after 6 months was a criterion for a positive response to CRT. We evaluated QRS duration, measured from a standard ECG before and after CRT implantation and obtained from mapping with NOGA XP system (AEMM); and the delay, measured with the implanted device algorithm (DCD) and its change after 6 months (ΔDCD); and selected delay parameters between the left and right ventricles based on AEMM data. A total of 24 patients presented with a positive response to CRT versus 9 non-responders. After CRT implantation, we observed differences between responders and non-responders group in the reduction of QRS duration (31 ms vs. 16 ms), duration of paced QRS (123 ms vs. 142 ms), and the change of ΔDCDMaximum (4.9 ms vs. 0.44 ms) and ΔDCDMean (7.7 ms vs. 0.9 ms). The difference in selected parameters obtained during AEMM in both groups was related to interventricular delay (40.3 ms vs. 18.6 ms). Concerning local activation time and left ventricular activation time, we analysed the delays in individual left ventricular segments. Predominant activation delay of the posterior wall middle segment was associated with a better response to CRT. Some AEMM parameters, paced QRS time of less than 120 ms and reduction of QRS duration greater than 20 ms predict the response to CRT. ΔDCD is associated with favourable electrical and structural remodelling.Clinical trial registration: SUM No. KNW/0022/KB1/17/15.

3rd Department of Cardiology Upper Silesian Medical Center Katowice Poland

Department of Electrocardiology and Heart Failure Medical University of Silesia Katowice Poland

Division of Cardiology and Structural Heart Diseases Medical University of Silesia Katowice Poland

Electrocardiology Department Upper Silesian Medical Center Katowice Poland

Interventional Cardiac Electrophysiology Group International Clinical Research Center St Anne's University Hospital in Brno Brno Czech Republic

See more in PubMed

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A, ESC Scientific Document Group 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368. PubMed DOI

Gold MR, Birgersdotter-Green U, Singh JP, Ellenbogen KA, Yu Y, Meyer TE, Seth M, Tchou PJ. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur. Heart J. 2011;32(20):2516–2524. doi: 10.1093/eurheartj/ehr329. PubMed DOI PMC

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. MADIT-CRT trial investigators, cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 2009;361(14):1329–1338. doi: 10.1056/nejmoa0906431. PubMed DOI

Carpio EF, Gomez JF, Sebastian R, Lopez-Perez A, Castellanos E, Almendral J, Ferrero JM, Trenor B. Optimization of lead placement in the right ventricle during cardiac resynchronization therapy. A simulation study. Front. Physiol. 2019;11(10):74. doi: 10.3389/fphys.2019.00074. PubMed DOI PMC

Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, Barrabés JA, Boriani G, Braunschweig F, Brignole M, Burri H, Coats AJS, Deharo JC, Delgado V, Diller GP, Israel CW, Keren A, Knops RE, Kotecha D, Leclercq C, Merkely B, Starck C, Thylén I, Tolosana JM, ESC Scientific Document Group 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur. Heart J. 2021;42(35):3427–3520. doi: 10.1093/eurheartj/ehab364. PubMed DOI

Rickard J, Michtalik H, Sharma R, Berger Z, Iyoha E, Green AR, Haq N, Robinson KA. Predictors of response to cardiac resynchronization therapy: A systematic review. Int. J. Cardiol. 2016;15(225):345–352. doi: 10.1016/j.ijcard.2016.09.078. PubMed DOI

Van Stipdonk A, Wijers S, Meine M, Vernooy KJ. ECG patterns in cardiac resynchronization therapy. Atr. Fibrillation. 2015;7(6):1214. doi: 10.4022/jafib.1214. PubMed DOI PMC

Jastrzebski M, Baranchuk A, Fijorek K, Kisiel R, Kukla P, Sondej T, Czarnecka D. Cardiac resynchronization therapy-induced acute shortening of QRS duration predicts long-term mortality only in patients with left bundle branch block. Europace. 2019;21(2):281–289. doi: 10.1093/europace/euy254. PubMed DOI

Takaya Y, Noda T, Nakajima I, Yamada Y, Miyamoto K, Okamura H, Satomi K, Aiba T, Kusano KF, Kanzaki H, Anzai T, Ishihara M, Yasuda S, Ogawa H, Kamakura S, Shimizu W. Electrocardiographic predictors of response to cardiac resynchronization therapy in patients with intraventricular conduction delay. Circ. J. 2014;78(1):71–77. doi: 10.1253/circj.cj-12-1569. PubMed DOI

Thebault C, Donal E, Meunier C, et al. Sites of left and right ventri-cular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur. Heart J. 2012;33:2662–2671. doi: 10.1093/eurheartj/ehr505. PubMed DOI

Saxon LA, Olshansky B, Volosin K, et al. Influence of left ventricular lead location on outcomes in the COMPANION study. J. Cardiovasc. Electrophysiol. 2009;20:764–768. doi: 10.1111/j.1540-8167.2009.01444.x. PubMed DOI

Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: The TARGET study: a randomized, controlled trial. J. Am. Coll. Cardiol. 2012;59:1509–1518. doi: 10.1016/j.jacc.2011.12.030. PubMed DOI

Gold MR, Yu Y, Singh JP, Birgersdotter-Green U, Stein KM, Wold N, Meyer TE, Ellenbogen KA. Effect of interventricular electrical delay on atrioventricular optimization for cardiac resynchronization therapy. Circ. Arrhythm. Electrophysiol. 2018;11(8):e006055. doi: 10.1161/circep.117.006055. PubMed DOI PMC

Polasek R, Kucera P, Nedbal P, Roubicek T, Belza T, Hanuliakova J, Horak D, Wichterle D, Kautzner Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up. J. BMC Cardiovasc Disord. 2012;12:34. doi: 10.1186/1471-2261-12-34. PubMed DOI PMC

Zanon F, et al. Determination of the longest intrapatient left ventricular electrical delay may predict acute hemodynamic improvement in patients after cardiac resynchronization therapy. Circ. Arrhythm. Electrophysiol. 2014;7:377–383. doi: 10.1161/circep.113.000850. PubMed DOI

Gold MR, Yu Y, Wold N, Day JD. The role of interventricular conduction delay to predict clinical response with cardiac resynchronization therapy. Heart Rhythm. 2017;14(12):1748–1755. doi: 10.1016/j.hrthm.2017.10.016. PubMed DOI

Ueda N, Noda T, Nakajima I, Ishibashi K, Nakajima K, Kamakura T, Wada M, Yamagata K, Inoue Y, Miyamoto K, Nagase S, Aiba T, Kiso K, Kanzaki H, Izumi C, Noguchi T, Yasuda S, Kusano K. Clinical impact of left ventricular paced conduction disturbance in cardiac resynchronization therapy. Heart Rhythm. 2020;17(11):1870–1877. doi: 10.1016/j.hrthm.2020.05.031. PubMed DOI

Strik M, van Deursen CJ, van Middendorp LB, et al. Transseptal conduction as an important determinant for cardiac resynchronization therapy, as revealed by extensive electrical mapping in the dyssynchronous canine heart. Circ. Arrhythm. Electrophysiol. 2013;6(4):682–689. doi: 10.1161/circep.111.000028. PubMed DOI

Kosztin A, Kutyifa V, Nagy VK, Geller L, Zima E, Molnar L, Szilagyi S, Ozcan EE, Szeplaki G, Merkely B. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients. Europace. 2016;18(4):550–9. doi: 10.1093/europace/euv117. PubMed DOI PMC

Engels EB, Mafi-Rad M, van Stipdonk AM, Vernooy K, Prinzen FW. Why QRS duration should be replaced by better measures of electrical activation to improve patient selection for cardiac resynchronization therapy. J. Cardiovasc. Transl. Res. 2016;9(4):257–65. doi: 10.1007/s12265-016-9693-1. PubMed DOI PMC

Rials SJ, Pershing M, Collins CJ. Guidewire method for measuring local left ventricular electrical activation time during cardiac resynchronization implantation. J. Innov. Card. Rhythm. Manag. 2018;9(1):2989–2995. doi: 10.19102/icrm.2018.090102. PubMed DOI PMC

Mafi-Rad M, Van't Sant J, Blaauw Y, Doevendans PA, Cramer MJ, Crijn HJ, Prinzen FW, Meine M, Vernooy K. Regional left ventricular electrical activation and peak contraction are closely related in candidates for cardiac resynchronization therapy. JACC Clin. Electrophysiol. 2017;3(8):854–862. doi: 10.1016/j.jacep.2017.03.014. PubMed DOI

Mafi Rad M, Blaauw Y, Dinh T, Pison L, Crijns HJ, Prinzen FW, Vernooy K. Different regions of latest electrical activation during left bundle-branch block and right ventricular pacing in cardiac resynchronization therapy patients determined by coronary venous electro-anatomic mapping. Eur. J Heart Fail. 2014;16(11):1214–1222. doi: 10.1002/ejhf.178. PubMed DOI

Vinther M, Risum N, Svendsen JH, Møgelvang R, Philbert BT. A randomized trial of his pacing versus biventricular pacing in symptomatic HF patients with left bundle branch block (his-alternative) JACC Clin. Electrophysiol. 2021;7(11):1422–1432. doi: 10.1016/j.jacep.2021.04.003. PubMed DOI

Kato H, Yanagisawa S, Sakurai T, Mizuno C, Ota R, Watanabe R, Suga K, Okada T, Murakami H, Kada K, Inden Y, Tsuboi N, Murohara T. Efficacy of his bundle pacing on LV relaxation and clinical improvement in HF and LBBB. JACC Clin. Electrophysiol. 2022;8(1):59–69. doi: 10.1016/j.jacep.2021.06.011. PubMed DOI

Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Mao G, Vijayaraman P, Ellenbogen KA. Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block. Heart. 2019;105(2):137–143. doi: 10.1136/heartjnl-2018-313415. PubMed DOI

Wang Y, Zhu H, Hou X, Wang Z, Zou F, Qian Z, Wei Y, Wang X, Zhang L, Li X, Liu Z, Xue S, Qin C, Zeng J, Li H, Wu H, Ma H, Ellenbogen KA, Gold MR, Fan X, Zou J. LBBP-RESYNC investigators. Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy. J. Am. Coll. Cardiol. 2022;80(13):1205–1216. doi: 10.1016/j.jacc.2022.07.019. PubMed DOI

Wolff PS, Winnicka A, Ciesielski A, Unkell M, Zawadzki G, Sławuta A, Gajek J. HOT CRT-The effective combination of conventional cardiac resynchronization and his bundle pacing. Medicina (Kaunas). 2022;58(12):1828. doi: 10.3390/medicina58121828. PubMed DOI PMC

Senes J, Mascia G, Bottoni N, Oddone D, Donateo P, Grimaldi T, Minneci C, Bertolozzi I, Brignole M, Puggioni E, Coluccia G. Is His-optimized superior to conventional cardiac resynchronization therapy in improving heart failure? Results from a propensity-matched study. Pacing Clin. Electrophysiol. 2021;44(9):1532–1539. doi: 10.1111/pace.14336. PubMed DOI